Literature DB >> 37596

Research in endorphins and schizophrenia.

G C Davis, M S Buchsbaum, W E Bunney.   

Abstract

It has been suggested that the newly discovered endogenous opiate peptides (called endorphins) might play a role in the symptoms of schizophrenia. The administration of narcotic antagonists provides both a test of the hypothesis and a potential treatment. In this article, we review the methods by which data have been gathered to test endorphin involvement in schizophrenia. Alternative strategies, which hold greater promise of producing conclusive positive or negative evidence, include exploitation of individual differences, use of psychophysiological measures, genetic strategies, and multivariate statistical techniques with larger sample sizes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 37596     DOI: 10.1093/schbul/5.2.244

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  2 in total

1.  Effect of naloxone on the state of patients with endogenous psychoses.

Authors:  R R Lideman; G P Panteleeva; F E Vartanyan; B S Belyaev
Journal:  Neurosci Behav Physiol       Date:  1984 Nov-Dec

Review 2.  Enkephalins and Endorphins. Clinical, pharmacological and therapeutic implications.

Authors:  D L Copolov; R D Helme
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.